Rockwell Medical, Inc. (RMTI) Stock Forecast
RMTI analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $20.00 average of analyst targets
- Upside to target
- +169.2% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-0.13
- 52-week range
- $5.19 – $12.60
RMTI analyst ratings
2 analystsNumber of analysts at each rating.
RMTI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
RMTI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.18 | −$0.23 | −$0.13 | −$0.50 | +64.0% | 2 |
| Current fiscal year (2026) | −$1.01 | −$1.12 | −$0.90 | −$1.50 | +32.7% | 2 |
| Next fiscal year (2027) | −$0.20 | −$0.77 | $0.36 | −$1.01 | +79.7% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
RMTI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $18.2M | $18.2M | $18.2M | +14.4% | 2 |
| Current fiscal year (2026) | $72.3M | $72.2M | $72.5M | +4.5% | 2 |
| Next fiscal year (2027) | $78.2M | $76.1M | $80.2M | +8.0% | 2 |
RMTI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
RMTI revenue: reported and forecast
RMTI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.15 | −$0.17 | −$0.17 | −$0.23 | −$0.18 | +20.0% | 0 up · 1 down |
| Current fiscal year (2026) | −$0.90 | −$0.88 | −$0.88 | −$1.12 | −$1.01 | +12.2% | 0 up · 2 down |
| Next fiscal year (2027) | −$0.05 | −$0.09 | −$0.09 | −$0.17 | −$0.20 | +310.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
RMTI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; RMTI beat in 7 of 12.
What analysts expect from RMTI
2 analysts cover Rockwell Medical; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.00, 169.2% above the latest close of $7.43. Analysts expect earnings of −$1.01 per share for 2026, +32.7% from a year earlier. For 2027 the average estimate is −$0.20 per share on revenue of $78.2 million. Rockwell Medical beat the EPS estimate in 7 of the last 12 quarters.
Related: RMTI income statement, RMTI key metrics, RMTI chart. See the RMTI stock overview for the latest quote and news.
RMTI forecast FAQ
What is Rockwell Medical's price target?
The average analyst price target for Rockwell Medical is $20.00, 169.2% above the latest close of $7.43.
Is Rockwell Medical a buy, hold or sell?
Of 2 analysts covering Rockwell Medical, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Rockwell Medical's EPS forecast?
Analysts forecast −$1.01 per share for 2026 (range −$1.12 to −$0.90); for 2027 the estimate is −$0.20.
What is Rockwell Medical's revenue forecast?
The average revenue estimate for 2026 is $72.3 million, growth of 4.5%; for 2027 it is $78.2 million.
When does Rockwell Medical report earnings?
Rockwell Medical is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 before the market opens; the EPS estimate is $-0.13.
Does Rockwell Medical usually beat earnings estimates?
Rockwell Medical reported EPS at or above the analyst estimate in 7 of the last 12 quarters.